SCHEMBL6235501

SCHEMBL6235501

CCCc1cc(C(C)C)c(O)cc1C

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 3/20 0.56
CYP2D6 P10635 4/20 0.54
CYP1A2 P05177 3/20 0.54
MAPK1 P28482 1/20 0.54
LMNA P02545 5/20 0.52
PKM P14618 2/20 0.47
TRPA1 O75762 1/20 0.41
CHRM1 P11229 1/20 0.41
SLC6A2 P23975 1/20 0.41
ADRA1A P35348 1/20 0.41
HTR2B P41595 1/20 0.41
MAPT P10636 4/20 0.38
GAA P10253 3/20 0.38
CYP2C9 P11712 3/20 0.38
ALOX15 P16050 3/20 0.38
CYP2C19 P33261 3/20 0.38
KMT2A Q03164 2/20 0.38
CYP3A4 P08684 2/20 0.38
HIF1A Q16665 2/20 0.38
THRB P10828 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6661840 0.89 TRPV1 (0.60) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL28228079 0.85 CYP1A2 (0.54) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL1245168 0.85 CYP1A2 (0.57) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL69265 0.82 CYP1A2 (0.58) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL6252526 0.81 CYP1A2 (0.57) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL5678026 0.80 HMGCR (0.45) TRPV1CYP2D6CYP1A2MAPK1PKM
SCHEMBL10633491 0.80 CYP2D6 (0.49) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL4436997 0.79 TRPV1 (0.74) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL23387409 0.78 HMGCR (0.53) TRPV1CYP2D6CYP1A2MAPK1LMNA
SCHEMBL14139877 0.78 NPSR1 (0.46) TRPV1CYP2D6CYP1A2MAPK1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1053744-B1 Substituted phenols as fragrance, flavor and antimicrobial compounds TAKASAGO PERFUMERY CO LTD (JP) 2005-04-27 EP claimed
EP-1053744-A2 Substituted phenols as fragrance, flavor and antimicrobial compounds Takasago International Corporation (JP) 2000-11-22 EP claimed
US-6110888-A PHENOL SUBSTITUTED WITH ONE OF: PROPYL OR PROPENYL; ONE OF: HYDROGEN OR ALKYL; AND ONE TO THREE C3-C5 ALKYL GROUPS; FRAGRANCE AND ANTIMICROBIAL PROPERTIES; USE SUCH AS IN MOUTHWASHES TAKASAGO INTERNATIONAL CORPORATION (JP) 2000-08-29 US claimed
US-20230276797-A1 DISINFECTANT SYSTEM BANISH, MICHELE 2023-09-07 US disclosed
US-20230276797-A1 DISINFECTANT SYSTEM BANISH, MICHELE 2023-09-07 US disclosed
CN-101490130-B Polycarbonate resin and optical film using the same MITSUBISHI GAS CHEMICAL CO 2012-11-07 CN disclosed
CN-101490130-A Polycarbonate resin and optical film using the same MITSUBISHI GAS CHEMICAL CO (JP) 2009-07-22 CN disclosed
EP-1053744-B1 Substituted phenols as fragrance, flavor and antimicrobial compounds TAKASAGO PERFUMERY CO LTD (JP) 2005-04-27 EP disclosed
EP-1053744-A2 Substituted phenols as fragrance, flavor and antimicrobial compounds Takasago International Corporation (JP) 2000-11-22 EP disclosed
US-6110888-A PHENOL SUBSTITUTED WITH ONE OF: PROPYL OR PROPENYL; ONE OF: HYDROGEN OR ALKYL; AND ONE TO THREE C3-C5 ALKYL GROUPS; FRAGRANCE AND ANTIMICROBIAL PROPERTIES; USE SUCH AS IN MOUTHWASHES TAKASAGO INTERNATIONAL CORPORATION (JP) 2000-08-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230276797-A1 DISINFECTANT SYSTEM FPR1, FPR2, FPR3 TRPV1 822/4885CYP2D6 1392/4885CYP1A2 812/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.